Clinical TrialID 3768
Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT03580616
Amyotrophic Lateral Sclerosis (ALS)
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 3768
- Evidence Id
- 3768
- Core Evidence Id
- 3768
- Source Clinical Trial Id
- 3742
- Herb2 Clinical Trial Id
- HBCT003742
- Nct Id
- NCT03580616
- Title
- Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)
- Status
- Terminated
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Amyotrophic Lateral Sclerosis (ALS)
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: L-Serine
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 43
- Outcome Measure
- Dose tolerability based on subject reporting, Dose tolerability is based on subject interviews and diary assessment evaluating the presence or absence of adverse events, 6 months
- Sponsor Collaborator
- Elijah W. Stommel|Brain Chemistry Labs, Institute for Ethnomedicine
- Funded By
- OTHER
- Location
- Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States
- Other Id
- D18095
- Start Date
- 2018-10-24
- Primary Completion Date
- 2022-08-03
- Completion Date
- 2022-12-20
- First Posted
- 2018-07-09
- Results First Posted
- Last Update Posted
- 2023-09-07
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT03580616
- Title Cn
- Title En
- Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)
- Bilingual Status
- semi_complete